G, B., P, T., L, P., E, C., R, F., C, R., . . . S, M. (2020). Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer. International journal of cancer, 147(2), 565. https://doi.org/10.1002/ijc.32935
Chicago Style (17th ed.) CitationG, Benvenuto, et al. "Expression Profiles of PRKG1, SDF2L1 and PPP1R12A Are Predictive and Prognostic Factors for Therapy Response and Survival in High-grade Serous Ovarian Cancer." International Journal of Cancer 147, no. 2 (2020): 565. https://doi.org/10.1002/ijc.32935.
MLA (9th ed.) CitationG, Benvenuto, et al. "Expression Profiles of PRKG1, SDF2L1 and PPP1R12A Are Predictive and Prognostic Factors for Therapy Response and Survival in High-grade Serous Ovarian Cancer." International Journal of Cancer, vol. 147, no. 2, 2020, p. 565, https://doi.org/10.1002/ijc.32935.